Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page
- Check5 days agoChange DetectedStandardized the disease name hyphenation to 'Alpha-1 antitrypsin deficiency'.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.4.2 is now shown, replacing v3.4.1, with no study content changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page version label was updated from v3.4.0 to v3.4.1. No core content, eligibility criteria, or study data appear to be altered based on the screenshot.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 appears on the page. The change affects only the version label and does not modify study content, eligibility, or results.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.